Combinatorial generation of variable fusion proteins in the Ewing family of tumours
- PMID: 8223458
- PMCID: PMC413872
- DOI: 10.1002/j.1460-2075.1993.tb06137.x
Combinatorial generation of variable fusion proteins in the Ewing family of tumours
Abstract
Balanced translocations involving band q12 of human chromosome 22 are the most frequent recurrent translocations observed in human solid tumours. It has been shown recently that this region encodes EWS, a protein with an RNA binding homologous domain. In Ewing's sarcoma and malignant melanoma of soft parts, translocations of band 22q12 to chromosome 11 and 12 result in the fusion of EWS with the transcription factors FLI-1 and ATF1, respectively. The present analysis of 89 Ewing's sarcomas and related tumours show that in addition to the expected EWS-FLI-1 fusion, the EWS gene can be fused to ERG, a transcription factor closely related to FLI-1 but located on chromosome 21. The position of the chromosome translocation breakpoints are shown to be restricted to introns 7-10 of the EWS gene and widely dispersed within introns 3-9 of the Ets-related genes. This heterogeneity generates a variety of chimeric proteins that can be detected by immuno-precipitation. On rare occasions, they may be associated with a truncated EWS protein arising from alternate splicing. All 13 different fusion proteins that were evidenced contained the N-terminal domain of EWS and the Ets domain of FLI-1 or ERG suggesting that oncogenic conversion is achieved by the linking of the two domains with no marked constraint on the connecting peptide.
Similar articles
-
A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.Nat Genet. 1994 Feb;6(2):146-51. doi: 10.1038/ng0294-146. Nat Genet. 1994. PMID: 8162068
-
DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma.Mol Cell Biol. 1994 May;14(5):3230-41. doi: 10.1128/mcb.14.5.3230-3241.1994. Mol Cell Biol. 1994. PMID: 8164678 Free PMC article.
-
Promiscuous partnerships in Ewing's sarcoma.Cancer Genet. 2011 Jul;204(7):351-65. doi: 10.1016/j.cancergen.2011.07.008. Cancer Genet. 2011. PMID: 21872822 Free PMC article. Review.
-
Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors.Cancer Genet Cytogenet. 1997 Aug;97(1):12-9. doi: 10.1016/s0165-4608(96)00326-3. Cancer Genet Cytogenet. 1997. PMID: 9242212
-
Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma.Cell Cycle. 2006 Sep;5(18):2049-53. doi: 10.4161/cc.5.18.3213. Epub 2006 Sep 15. Cell Cycle. 2006. PMID: 16969112 Review.
Cited by
-
Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor.Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1028-32. doi: 10.1073/pnas.92.4.1028. Proc Natl Acad Sci U S A. 1995. PMID: 7862627 Free PMC article.
-
Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript.Am J Pathol. 1995 Dec;147(6):1592-9. Am J Pathol. 1995. PMID: 7495284 Free PMC article.
-
Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets.Annu Rev Pathol. 2012;7:145-59. doi: 10.1146/annurev-pathol-011110-130237. Epub 2011 Sep 19. Annu Rev Pathol. 2012. PMID: 21942527 Free PMC article. Review.
-
Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data.Br J Cancer. 1994 Nov;70(5):908-13. doi: 10.1038/bjc.1994.419. Br J Cancer. 1994. PMID: 7524604 Free PMC article.
-
Abnormalities of the FHIT transcripts in osteosarcoma and Ewing sarcoma.Jpn J Cancer Res. 1998 Sep;89(9):887-94. doi: 10.1111/j.1349-7006.1998.tb00645.x. Jpn J Cancer Res. 1998. PMID: 9818023 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical